This systematic review synthesizes findings from 35 studies involving over 6,000 critically ill adult patients and evaluates the diagnostic performance of three of the most widely studied AKI biomarkers: NGAL, KIM-1, and TIMP-2·IGFBP7. Here, LCN2 is linked to acute kidney injury.